{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:53:07Z","timestamp":1747169587648,"version":"3.40.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","prrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prrv.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T18:19:35Z","timestamp":1496254775000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Postnatal steroids in extreme preterm infants: Intra-tracheal instillation using surfactant as a vehicle"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1970-2486","authenticated-orcid":false,"given":"L.","family":"Boel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-6532","authenticated-orcid":false,"given":"M.","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2017.05.002_b0005","doi-asserted-by":"crossref","first-page":"e7976","DOI":"10.1136\/bmj.e7976","article-title":"Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)","volume":"345","author":"Costeloe","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.prrv.2017.05.002_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004454.pub2","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review)","author":"Roberts","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007836","article-title":"Animal derived surfactant extract for treatment of respiratory distress syndrome (Review)","author":"Seger","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000510.pub2","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants (Review)","author":"Rojas-Reyes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/bdra.23235","article-title":"Epidemiology of bronchopulmonary dysplasia","volume":"100","author":"Jensen","year":"2014","journal-title":"Birth Defects Res Part A - Clin Mol Teratol"},{"key":"10.1016\/j.prrv.2017.05.002_b0030","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMra067279","article-title":"Chronic lung disease after premature birth","volume":"357","author":"Baraldi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2017.05.002_b0035","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1542\/peds.2008-1827","article-title":"The cost of preterm birth throughout childhood in England and Wales","volume":"123","author":"Mangham","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2017.05.002_b0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1164\/rccm.201412-2142PP","article-title":"Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia","volume":"192","author":"Islam","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2017.05.002_b0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2012-203079","article-title":"Effect of preterm birth on later FEV1: a systematic review and meta-analysis","volume":"68","author":"Kotecha","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2017.05.002_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1469-8749.2007.02011.x","article-title":"Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants","volume":"50","author":"Jeng","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.prrv.2017.05.002_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/adc.85.6.463","article-title":"Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection","volume":"85","author":"Greenough","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.prrv.2017.05.002_b0060","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","article-title":"Impact of Bronchopulmonary Dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months","volume":"289","author":"Schmidt","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.prrv.2017.05.002_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000209301","article-title":"Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia","volume":"95","author":"Speer","year":"2009","journal-title":"Neonatology"},{"key":"10.1016\/j.prrv.2017.05.002_b0070","first-page":"173","article-title":"Biomarkers in bronchopulmonary dysplasia","volume":"14","author":"Bhandari","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.prrv.2010.03.002","article-title":"Acute lung injury in preterm newborn infants: mechanisms and management","volume":"11","author":"Chakraborty","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1542\/peds.2010-3875","article-title":"Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?","volume":"128","author":"Wright","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2017.05.002_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000351015","article-title":"Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity","volume":"104","author":"Chakraborty","year":"2013","journal-title":"Neonatology"},{"key":"10.1016\/j.prrv.2017.05.002_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0114524","article-title":"Role of serine proteases in the regulation of interleukin-877 during the development of bronchopulmonary dysplasia in preterm ventilated infants","volume":"9","author":"Chakraborty","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prrv.2017.05.002_b0095","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1542\/peds.2008-0526","article-title":"Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants","volume":"123","author":"Ambalavanan","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2017.05.002_b0100","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1038\/ncomms9977","article-title":"The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia","volume":"6","author":"Liao","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.prrv.2017.05.002_b0105","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.4049\/jimmunol.1500906","article-title":"IL-1\u03b2 and inflammasome activity link inflammation to abnormal fetal airway development","volume":"196","author":"Stouch","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.prrv.2017.05.002_b0110","article-title":"Early (<8days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Review)","author":"Doyle","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0115","article-title":"Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Review)","author":"Halliday","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-1-1","article-title":"The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs","volume":"1","author":"Barrington","year":"2001","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.prrv.2017.05.002_b0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000286210","article-title":"Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.prrv.2017.05.002_b0130","article-title":"Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants (Review)","author":"Doyle","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0135","article-title":"Moderately early (7\u201314 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Review)","author":"Halliday","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000286212","article-title":"Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.prrv.2017.05.002_b0145","article-title":"Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Review)","author":"Halliday","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.2008-2793","article-title":"Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants","volume":"124","author":"Yoder","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2017.05.002_b0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000279992","article-title":"Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.prrv.2017.05.002_b0160","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2017.05.002_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002311.pub3","article-title":"Late (\u22657days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants (Review)","volume":"4","author":"Onland","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0170","article-title":"Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Review)","volume":"5","author":"Shah","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0175","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Review)","author":"Shah","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0180","article-title":"Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants","volume":"5","author":"Shah","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2017.05.002_b0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ppul.1950100217","article-title":"Delivery of aerosolized medication to intubated babies","volume":"10","author":"Watterberg","year":"1991","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2017.05.002_b0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","article-title":"Early inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"373","author":"Bassler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2017.05.002_b0195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1203\/00006450-199804000-00018","article-title":"Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits","volume":"43","author":"Fajardo","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.prrv.2017.05.002_b0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1183\/20734735.006513","article-title":"Pulmonary surfactant in newborn infants and children","volume":"9","author":"Chakraborty","year":"2013","journal-title":"Breathe"},{"key":"10.1016\/j.prrv.2017.05.002_b0205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1164\/ajrccm\/144.4.909","article-title":"Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs","volume":"144","author":"Kharasch","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2017.05.002_b0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1440-1681.2002.03712.x","article-title":"Intratracheal administration of glucocorticoids using surfactant as a vehicle","volume":"29","author":"Nimmo","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.prrv.2017.05.002_b0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pedneo.2014.04.009","article-title":"Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice","volume":"56","author":"Huang","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.prrv.2017.05.002_b0220","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1039\/C1SM06444D","article-title":"Biophysical interaction between corticosteroids and natural surfactant preparation: implications for pulmonary drug delivery using surfactant as a carrier","volume":"8","author":"Wang","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.prrv.2017.05.002_b0225","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1152\/jappl.2000.89.3.884","article-title":"Effect of budesonide and salbutamol on surfactant properties","volume":"89","author":"Palmer","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.prrv.2017.05.002_b0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/pr.2011.78","article-title":"Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant","volume":"71","author":"Zhang","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.prrv.2017.05.002_b0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.resp.2016.07.009","article-title":"Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids","volume":"233","author":"Cimato","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.prrv.2017.05.002_b0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1875-9572(10)60042-3","article-title":"Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model","volume":"51","author":"Yang","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.prrv.2017.05.002_b0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ppul.22564","article-title":"Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant-depleted newborn piglets","volume":"48","author":"Yang","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2017.05.002_b0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000328928","article-title":"Natural surfactant combined with beclomethasone decreases lung inflammation in the preterm lamb","volume":"82","author":"Dani","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.prrv.2017.05.002_b0255","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ppul.21145","article-title":"Natural surfactant combined with beclomethasone decreases oxidative lung injury in the preterm lamb","volume":"44","author":"Dani","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2017.05.002_b0260","article-title":"Budesonide added to modified porcine surfactant curosurf may additionally improve the lung functions in meconium aspiration syndrome","volume":"62","author":"Mikolka","year":"2013","journal-title":"Physiol Res"},{"key":"10.1016\/j.prrv.2017.05.002_b0265","first-page":"57","article-title":"Effects of surfactant\/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury","volume":"67","author":"Mikolka","year":"2016","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.prrv.2017.05.002_b0270","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00003246-200111000-00020","article-title":"Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury","volume":"29","author":"Chen","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.prrv.2017.05.002_b0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1574884710666150929100210","article-title":"Pharmacokinetics of budesonide administered with surfactant in premature lambs: implications for neonatal clinical trials","volume":"11","author":"Roberts","year":"2016","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.prrv.2017.05.002_b0280","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","article-title":". Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2017.05.002_b0285","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S0091-6749(99)70059-X","article-title":"Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid","volume":"104","author":"Szefler","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.prrv.2017.05.002_b0290","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","article-title":"Antiinflammatory effects of Budesonide in human fetal lung","volume":"55","author":"Barrette","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prrv.2017.05.002_b0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal Administration of Budesonide\/Surfactant to Prevent Bronchopulmonary Dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2017.05.002_b0300","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpeds.2009.10.049","article-title":"A Follow-up Study of Preterm Infants Given Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants","volume":"156","author":"Kuo","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.prrv.2017.05.002_b0305","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003495-200060050-00010","article-title":"Budesonide inhalation suspension A review of its use in infants, children and adults with inflammatory respiratory disorders","volume":"60","author":"Hvizdos","year":"2000","journal-title":"Drugs"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054217300416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054217300416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T04:28:16Z","timestamp":1535776096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054217300416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":61,"alternative-id":["S1526054217300416"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2017.05.002","relation":{},"ISSN":["1526-0542"],"issn-type":[{"type":"print","value":"1526-0542"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postnatal steroids in extreme preterm infants: Intra-tracheal instillation using surfactant as a vehicle","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}